HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
On 17 November 2017, leaders of major pharmaceutical and medical technology companies, multilateral organizations, donors, governments, organizations providing or supporting services for children living with HIV, and other key stakeholders participated in a High-Level Discussion on Scaling Up Early Diagnosis and Treatment of Children and Adolescents. The meeting was convened by His Eminence Peter Appiah Kodowo Cardinal Turkson, Prefect of the Dicastery for the Promotion of Integral Human Development, with PEPFAR, UNAIDS, and Caritas Internationalis, and in close collaboration with the World Council of Churches-Ecumenical Advocacy Alliance, WHO, and EGPAF.
In recognition of the urgency of making more optimal pediatric ARV formulations available in 2018 and beyond, the participants of the High-Level Dialogue agreed to the following good faith commitments to focus, accelerate, and collaborate on the development, registration, introduction, and roll-out of the most optimal pediatric formulations and diagnostics: